Fixed Price IPO | ₹12 Cr | Listed at BSE SME | Tue, Aug 29, 2017 - Thu, Aug 31, 2017
ANG Lifesciences IPO is a fixed price issue of ₹12.01 crores. The issue is entirely a fresh issue of 0.15 crore shares of ₹12.01 crore.
ANG Lifesciences IPO bidding started from Aug 29, 2017 and ended on Aug 31, 2017. The shares got listed on BSE SME on Sep 8, 2017.
ANG Lifesciences IPO price is ₹80 per share. The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,28,000 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,56,000.
Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Guiness Securities Ltd..
Refer to ANG Lifesciences IPO RHP for detailed Information.
IPO Open
Tue, Aug 29, 2017
IPO Close
Thu, Aug 31, 2017
Issue Price
₹80 per share
Market Cap (Pre-IPO)
₹41.47 Cr
| IPO Date | 29 to 31 Aug, 2017 |
| Listed on | Fri, Sep 8, 2017 |
| Face Value | ₹10 per share |
| Issue Price | ₹80 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 15,00,800 shares (agg. up to ₹12 Cr) |
| Reserved for Market Maker | 76,800 shares Guiness Securities Ltd. (agg. up to ₹0.6144 Cr) |
| Fresh Issue (Ex Market Maker) | 14,24,000 shares (agg. up to ₹11 Cr) |
| Net Offered to Public | 14,24,000 shares (agg. up to ₹11 Cr) |
| Share Holding Pre Issue | 36,82,515 shares |
| Share Holding Post Issue | 51,83,315 shares |
| BSE Script Code | 540694 |
| ISIN | INE236W01016 |
ANG Lifesciences IPO comprises a total issue size of 15,00,800 shares. The net offer to the public is 14,24,000 shares, after excluding 76,800 shares allotted on a firm basis. Of the Net offer 7,12,000 (50.00%) allocated to NII 7,12,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 7,12,000 | 50.00% | 47.44% |
| Retail Shares Offered | 7,12,000 | 50.00% | 47.44% |
| Firm Reservations | |||
| Market Maker Shares Offered | 76,800 | 5.12% | |
| Total Shares Offered | 15,00,800 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,600 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,28,000 |
| Retail (Max) | 1 | 1,600 | ₹1,28,000 |
| HNI (Min) | 2 | 3,200 | ₹2,56,000 |
Incorporated in 2006, ANG Lifesciences India Limited is a pharmaceutical company whose engaged in the business of manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India.
Company's products include sterile dry powder vials for anti-biotics, anti-ulcerant, glucocorticoid and anti-inflammatory, anti-malarial, and anesthetic. It manufactures products in compliance with GMP requirements.
However, Company that currently operates at an average capacity utilization of 70% for last two fiscals hopes to achieve 90% plus in coming years. ANGL is likely to consider acquisition options as well to enhance its manufacturing capacities. Its customer list includes Wockhardt, DHS Maharashtra, Global Hospitals, Elder, Emcure, BPPI, Govt. of Haryana, Hetero Healthcare etc.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To meet the working capital requirement | 11.64 |
| 2 | To meet the Issue Expenses | 0.37 |
The ANG Lifesciences IPO is subscribed [.] times on August 31, 2017 5:00:00 PM (Day 3). The public issue subscribed [.] times in the retail category, [.] times in the QIB category, and [.] times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | [.] | 7,12,000 | 36,54,400 |
| Retail | [.] | 7,12,000 | 80,91,200 |
| Total | [.] | 14,24,000 | 1,17,45,600 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue management fees including fees selling commissions, brokerages, and payment to other intermediaries such as Legal Advisors, Registrars and other out of pocket expenses. | 0.28 |
| 2 | Printing & Stationery, Distribution, Postage, etc | 0.03 |
| 3 | Advertisement & Marketing Expenses | 0.03 |
| 4 | Regulatory & other expenses | 0.03 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹80.00 |
| Open | ₹96.00 |
| Low | ₹96.00 |
| High | ₹96.00 |
| Last Trade | ₹96.00 |
Lead Manager Reports
ANG Lifesciences IPO is a SME IPO of 15,00,800 equity shares of the face value of ₹10 aggregating up to ₹12 Crores. The issue is priced at ₹80 per share. The minimum order quantity is 1600.
The IPO opens on Tue, Aug 29, 2017, and closes on Thu, Aug 31, 2017.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in ANG Lifesciences IPO using UPI as a payment gateway. Zerodha customers can apply in ANG Lifesciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in ANG Lifesciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The ANG Lifesciences IPO opens on Tue, Aug 29, 2017 and closes on Thu, Aug 31, 2017.
ANG Lifesciences IPO lot size is 1600, and the minimum amount required for application is ₹1,28,000.
You can apply in ANG Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for ANG Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the ANG Lifesciences IPO allotment status.
The ANG Lifesciences IPO listing date is on Fri, Sep 8, 2017.
